10:48 Debate: Frontline Regimen for Newly Diagnosed Transplant Ineligible Myeloma - Two Drugs HMP Education
16:40 Debate: Frontline Regimen for Newly Diagnosed Transplant Ineligible Myeloma - Three Drugs HMP Education
13:37 Debate: Optimal Induction Therapy for Newly Diagnosed Transplant Eligible Myeloma - Triplets HMP Education
17:31 Debate: Optimal Induction Therapy for Newly Diagnosed Transplant Eligible Myeloma - Quadruplets HMP Education
14:02 Debate: Best Frontline Regimen for a CLL Patient Aged 60 Who Requires Therapy - FCR HMP Education
14:48 Debate: Best Frontline Regimen for a CLL Patient Aged 60 Who Requires Therapy - Ibrutinib HMP Education
11:23 Debate: Best Approach for Multiple Relapsed CLL after Chemoimmunotherapy - Kinase inhibitor HMP Education
19:14 Debate: Best Approach for Multiple Relapsed CLL after Chemoimmunotherapy - Other Novel Agents HMP Education
21:44 How Should Chronic-phase CML Management be Influenced by RT-PCR Results at 3 Months+ HMP Education
22:06 Myelofibrosis Prognostic Scoring Systems: IPSS, DIPSS, DIPSS-Plus, MISPS, and GIPSS HMP Education
15:48 Debate: Should JAK2 inhibitors be used for lower-risk MF, or only on-label (higher-risk)? - Yes HMP Education
17:09 Debate: Should JAK2 inhibitors be used for lower-risk MF, or only on-label (higher-risk)? - Not yet HMP Education
13:07 Debate: A Case of Stage IV Follicular Lymphoma - Rituximab or "Biological Doublet" Therapy HMP Education
23:37 Kinase Inhibitors and Immunomodulatory Drugs - What does the future hold for lymphomas? HMP Education
13:31 Debate: A Case of Advanced Stage Mantle Cell Lymphoma - Chemoimmunotherapy with AutoSCT HMP Education
14:10 Debate: A Case of Advanced Stage Mantle Cell Lymphoma - Chemo-based therapy without transplant HMP Education
12:05 Debate: Should DLBCL Patients be Treated Differently Based on Cell of Origin? - Yes HMP Education
9:30 Debate: Should DLBCL Patients be Treated Differently Based on Cell of Origin? - No HMP Education
